Lista de obras -

1H, 13C and 15N resonance assignments for domain III of the West Nile virus envelope protein

artículo científico publicado en 2004

A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus.

artículo científico publicado en 2006

A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice.

artículo científico publicado en 2006

Adaptation of yellow fever virus 17D to Vero cells is associated with mutations in structural and non-structural protein genes

artículo científico publicado en 2013

Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development

artículo científico publicado en 2018

Baseline mapping of severe fever with thrombocytopenia syndrome virology, epidemiology and vaccine research and development

scientific article published on 17 December 2020

Characterization of Culex Flavivirus (Flaviviridae) strains isolated from mosquitoes in the United States and Trinidad

artículo científico publicado en 2009

Characterization of a West Nile virus isolate from a human on the Gulf Coast of Texas

artículo científico publicado en 2004

Co-circulation of West Nile virus variants, Arizona, USA, 2010

artículo científico publicado en 2014

Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypes ⬇️

artículo científico publicado el 5 de diciembre de 2011

Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection

artículo científico publicado en 2017

Current use and development of vaccines for Japanese encephalitis

artículo científico publicado en 2008

Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus

artículo científico publicado en 2009

Development of Resistance to Passive Therapy with a Potently Neutralizing Humanized Monoclonal Antibody against West Nile Virus

artículo científico publicado en 2009

Development pathway for biodefense vaccines

artículo científico publicado en 2009

Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains

artículo científico publicado en 2005

ELISA and Neutralization Methods to Measure Anti-West Nile Virus Antibody Responses

artículo científico publicado en 2016

Emergence of attenuated West Nile virus variants in Texas, 2003.

artículo científico publicado en 2004

Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs

artículo científico publicado en 2014

Envelope and pre-membrane protein structural amino acid mutations mediate diminished avian growth and virulence of a Mexican West Nile virus isolate

artículo científico publicado en 2011

Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains

artículo científico publicado en 2005

Erratum: Publisher Correction: New international guidance on quality, safety and efficacy of DNA vaccines

artículo científico publicado en 2020

Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection

artículo científico publicado en 2004

First vaccine approval under the FDA Animal Rule

artículo científico publicado en 2016

GeneSV - an Approach to Help Characterize Possible Variations in Genomic and Protein Sequences

artículo científico publicado en 2014

Genetic Variation among Temporally and Geographically Distinct West Nile Virus Isolates, United States, 2001, 2002

artículo científico publicado en 2003

Genetic variation of St. Louis encephalitis virus

artículo científico publicado en 2008

Genome sequence and attenuating mutations in West Nile virus isolate from Mexico

artículo científico publicado en 2004

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein

artículo científico publicado en 2002

Immunogenicity and efficacy of flagellin-envelope fusion dengue vaccines in mice and monkeys

artículo científico publicado en 2015

Introductions of West Nile virus strains to Mexico

artículo científico publicado en 2006

Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States

artículo científico publicado en 2003

Long range communication in the envelope protein domain III and its effect on the resistance of West Nile virus to antibody-mediated neutralization

artículo científico publicado en 2007

Molecular evolution of lineage 2 West Nile virus ⬇️

artículo científico publicado el 7 de noviembre de 2012

Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype

artículo científico publicado en 2002

Multiplexed digital mRNA profiling of the inflammatory response in the West Nile Swiss Webster mouse model

artículo científico publicado en 2014

Mutational analysis of the West Nile virus NS4B protein ⬇️

artículo científico publicado el 6 de febrero de 2012

NMR assignments of the sylvatic dengue 1 virus envelope protein domain III

artículo científico publicado en 2008

Natural and nosocomial infection in a patient with West Nile encephalitis and extrapyramidal movement disorders

artículo científico publicado en 2003

New international guidance on quality, safety and efficacy of DNA vaccines

artículo científico publicado en 2020

Origin and Evolution of Japanese Encephalitis Virus in Southeast Asia

artículo científico publicado en 2003

Persistent Infection with West Nile Virus Years after Initial Infection

artículo científico publicado en 2010

Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype

artículo científico publicado en 2005

Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III.

artículo científico publicado en 2016

Propagation and Titration of West Nile Virus on Vero Cells

artículo científico publicado en 2016

Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine

artículo científico publicado en 2004

Real-time reverse transcriptase-polymerase chain reaction quantification of West Nile virus transmitted by Culex pipiens quinquefasciatus.

artículo científico publicado en 2004

Recent advances in the molecular biology of west nile virus

artículo científico publicado en 2005

Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence

artículo científico publicado en 2016

Reduced Avian Virulence and Viremia of West Nile Virus Isolates from Mexico and Texas ⬇️

artículo científico publicado el 1 de octubre de 2011

Resurgence of West Nile neurologic disease in the United States in 2012: What happened? What needs to be done? ⬇️

artículo científico publicado el 26 de abril de 2013

Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III

artículo científico publicado en 2010

Safety and immunogenicity of a chimeric vaccine for West Nile virus in aged subjects ⬇️

artículo científico publicado el 1 de mayo de 2011

Selection of thioaptamers for diagnostics and therapeutics.

artículo científico publicado en 2006

Short report: serological evidence of West Nile virus activity in El Salvador

artículo científico publicado en 2005

Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus

artículo científico publicado en 2004

Solution structure of the envelope protein domain III of dengue-4 virus

artículo científico publicado en 2007

Status of research and development of vaccines for chikungunya

artículo científico publicado en 2016

Structure of the envelope protein domain III of Omsk hemorrhagic fever virus.

artículo científico publicado en 2006

Structure of yellow fever virus envelope protein domain III

artículo científico publicado en 2009

Supramolecular peptide hydrogel adjuvanted subunit vaccine elicits protective antibody responses against West Nile virus

artículo científico publicado en 2016

Thermodynamic mechanism for the evasion of antibody neutralization in flaviviruses

artículo científico publicado en 2014

Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections

artículo científico

Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection

artículo científico publicado en 2004

Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection

artículo científico publicado en 2015

Vaccines and Immunotherapeutics for the Prevention and Treatment of Infections with West Nile Virus ⬇️

artículo científico publicado el 1 de febrero de 2011

West Nile encephalitis

artículo científico publicado en 2003

West Nile virus in Mexico: evidence of widespread circulation since July 2002.

artículo científico publicado en 2003

Yellow fever virus: genetic and phenotypic diversity and implications for detection, prevention and therapy

artículo científico

Lista de obras de

1H, 13C and 15N resonance assignments for domain III of the West Nile virus envelope protein

A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus.

A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice.

Adaptation of yellow fever virus 17D to Vero cells is associated with mutations in structural and non-structural protein genes

Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development

Baseline mapping of severe fever with thrombocytopenia syndrome virology, epidemiology and vaccine research and development

Characterization of Culex Flavivirus (Flaviviridae) strains isolated from mosquitoes in the United States and Trinidad

Characterization of a West Nile virus isolate from a human on the Gulf Coast of Texas

Co-circulation of West Nile virus variants, Arizona, USA, 2010

Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypes ⬇️

Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection

Current use and development of vaccines for Japanese encephalitis

Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus

Development of Resistance to Passive Therapy with a Potently Neutralizing Humanized Monoclonal Antibody against West Nile Virus

Development pathway for biodefense vaccines

Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains

ELISA and Neutralization Methods to Measure Anti-West Nile Virus Antibody Responses

Emergence of attenuated West Nile virus variants in Texas, 2003.

Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs

Envelope and pre-membrane protein structural amino acid mutations mediate diminished avian growth and virulence of a Mexican West Nile virus isolate

Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains

Erratum: Publisher Correction: New international guidance on quality, safety and efficacy of DNA vaccines

Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection

First vaccine approval under the FDA Animal Rule

GeneSV - an Approach to Help Characterize Possible Variations in Genomic and Protein Sequences

Genetic Variation among Temporally and Geographically Distinct West Nile Virus Isolates, United States, 2001, 2002

Genetic variation of St. Louis encephalitis virus

Genome sequence and attenuating mutations in West Nile virus isolate from Mexico

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein

Immunogenicity and efficacy of flagellin-envelope fusion dengue vaccines in mice and monkeys

Introductions of West Nile virus strains to Mexico

Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States

Long range communication in the envelope protein domain III and its effect on the resistance of West Nile virus to antibody-mediated neutralization

Molecular evolution of lineage 2 West Nile virus ⬇️

Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype

Multiplexed digital mRNA profiling of the inflammatory response in the West Nile Swiss Webster mouse model

Mutational analysis of the West Nile virus NS4B protein ⬇️

NMR assignments of the sylvatic dengue 1 virus envelope protein domain III

Natural and nosocomial infection in a patient with West Nile encephalitis and extrapyramidal movement disorders

New international guidance on quality, safety and efficacy of DNA vaccines

Origin and Evolution of Japanese Encephalitis Virus in Southeast Asia

Persistent Infection with West Nile Virus Years after Initial Infection

Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype

Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III.

Propagation and Titration of West Nile Virus on Vero Cells

Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine

Real-time reverse transcriptase-polymerase chain reaction quantification of West Nile virus transmitted by Culex pipiens quinquefasciatus.

Recent advances in the molecular biology of west nile virus

Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence

Reduced Avian Virulence and Viremia of West Nile Virus Isolates from Mexico and Texas ⬇️

Resurgence of West Nile neurologic disease in the United States in 2012: What happened? What needs to be done? ⬇️

Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III

Safety and immunogenicity of a chimeric vaccine for West Nile virus in aged subjects ⬇️

Selection of thioaptamers for diagnostics and therapeutics.

Short report: serological evidence of West Nile virus activity in El Salvador

Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus

Solution structure of the envelope protein domain III of dengue-4 virus

Status of research and development of vaccines for chikungunya

Structure of the envelope protein domain III of Omsk hemorrhagic fever virus.

Structure of yellow fever virus envelope protein domain III

Supramolecular peptide hydrogel adjuvanted subunit vaccine elicits protective antibody responses against West Nile virus

Thermodynamic mechanism for the evasion of antibody neutralization in flaviviruses

Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections

Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection

Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection

Vaccines and Immunotherapeutics for the Prevention and Treatment of Infections with West Nile Virus ⬇️

West Nile encephalitis

West Nile virus in Mexico: evidence of widespread circulation since July 2002.

Yellow fever virus: genetic and phenotypic diversity and implications for detection, prevention and therapy